DNA methylation-associated inactivation of TGFβ-related genes, DRM/Gremlin, RUNX3, and HPP1 in human cancers

The transforming growth factor β (TGFβ)-signalling pathway is deregulated in many cancers. We examined the role of gene silencing via aberrant methylation of DRM/Gremlin and HPP1, which inhibit TGFβ signalling, and RUNX3, which facilitates TGFβ-signalling, of all genes that are thought to be tumour suppressors, are aberrantly expressed, and are thus thought to have important role in human cancers. We examined DRM/Gremlin mRNA expression in 44 cell lines and the promoter methylation status of DRM/Gremlin, HPP1, and RUNX3 in 44 cell lines and 511 primary tumours. The loss of DRM/Gremlin mRNA expression in human cancer cell lines is associated with DNA methylation, and treatment with the methylation inhibitor-reactivated mRNA expression (n=13). Methylation percentages of the three genes ranged from 0–83% in adult tumours and 0–50% in paediatric tumours. Methylation of DRM/Gremlin was more frequent in lung tumours in smokers, and methylation of all three genes was inversely correlated with prognosis in patients with bladder or prostate cancer. Our results provide strong evidence that these TGFβ-related genes are frequently deregulated through aberrant methylation in many human malignancies.

• Publication year

  2005

• Venue

  British Journal of Cancer

• Publication date

  2005-10-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/bjc.2013.776PMID 24327071PMCID 3859959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follistatin

  2020cited by this paper
• Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection

  2014cited by this paper
• Methylation and Gene Silencing of the Ras-Related GTPase Gene in Lung and Breast Cancers

  2007cited by this paper
• Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

  2004cited by this paper
• Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.

  2004cited by this paper
• Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer

  2004cited by this paper
• RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

  2004cited by this paper
• Regulation of ovarian function by the TGF-beta superfamily and follistatin.

  2003cited by this paper
• Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.

  2003cited by this paper
• Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

  2003cited by this paper
• Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

  2003cited by this paper
• The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells.

  2003cited by this paper
• BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels.

  2003cited by this paper
• Increased expression of bone morphogenetic protein‐7 in bone metastatic prostate cancer

  2003cited by this paper
• Repression of the TMEFF2 promoter by c-Myc.

  2003cited by this paper
• The two faces of transforming growth factor beta in carcinogenesis.

  2003cited by this paper
• Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples

  2003cited by this paper
• Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning

  2003cited by this paper
• The two faces of transforming growth factor β in carcinogenesis

  2003cited by this paper
• Alterations in the mitochondrial displacement loop in lung cancers.

  2003cited by this paper
• Causal relationship between the loss of RUNX3 expression and gastric cancer.

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells

  2002cited by this paper
• Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation.

  2002cited by this paper
• The other side of TGF-beta superfamily signal regulation: thinking outside the cell.

  2002cited by this paper
• Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas.

  2002cited by this paper
• Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.

  2002cited by this paper
• Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

  2002cited by this paper
• Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators.

  2002cited by this paper
• Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor

  2002cited by this paper
• The other side of TGF-β superfamily signal regulation: thinking outside the cell

  2002cited by this paper
• DNA methylation profiles of lung tumors.

  2001cited by this paper
• p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.

  2001cited by this paper
• p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer

  2001cited by this paper
• Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis.

  2001cited by this paper
• HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers.

  2001cited by this paper
• IHG-2, a Mesangial Cell Gene Induced by High Glucose, Is Human gremlin

  2000cited by this paper
• Role of Transforming Growth Factor-β Signaling in Cancer

  2000cited by this paper
• Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.

  2000cited by this paper
• The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells.

  2000cited by this paper
• DRM/GREMLIN (CKTSF1B1) maps to human chromosome 15 and is highly expressed in adult and fetal brain

  2000cited by this paper
• Role of transforming growth factor-beta signaling in cancer.

  2000cited by this paper
• Replication error in human breast cancer: comparison with clinical variables and family history of cancer.

  1999cited by this paper
• Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival

  1999cited by this paper
• A mouse cerberus/Dan-related gene family.

  1999cited by this paper
• Bone Morphogenetic Protein 2 Inhibits Platelet-derived Growth Factor-induced c-fos Gene Transcription and DNA Synthesis in Mesangial Cells

  1999cited by this paper
• Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds

  1999cited by this paper
• A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells.

  1999cited by this paper
• The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb.

  1999cited by this paper
• Characterization of paired tumor and non‐tumor cell lines established from patients with breast cancer

  1998cited by this paper
• The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities.

  1998cited by this paper
• Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Deletion mapping of chromosome 2 in human lung carcinoma

  1996cited by this paper
• NCI‐navy medical oncology branch cell line data base

  1996cited by this paper
• CpG islands in vertebrate genomes.

  1987cited by this paper

• DNA Methyltransferase 3A: a Significant Target for the Discovery of Inhibitors as Potent Anticancer Drugs.

  2023cites this paper
• [The Mechanism of GREM1's Effect on Osteogenic/Odontogenic Differentiation of Stem Cells from Apical Papilla].

  2021cites this paper
• Evaluation of Epigenetic and Radiomodifying Effects during Radiotherapy Treatments in Zebrafish

  2021cites this paper
• HPP1 Ectodomain Shedding is Mediated by ADAM17 and is Necessary for Tumor Suppression in Colon Cancer.

  2020cites this paper
• Secreted BMP antagonists and their role in cancer and bone metastases.

  2020cites this paper
• Downregulation of RUNX3 has a poor prognosis and promotes tumor progress in kidney cancer.

  2020cites this paper
• Endometriosis and cancerogenesis of the ovaries (a review)

  2018cites this paper
• RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer

  2018cites this paper
• Runx Genes in Breast Cancer and the Mammary Lineage.

  2017cites this paper
• Are targeted therapies for diabetic cardiomyopathy on the horizon?

  2017cites this paper
• RUNX transcription factors drive epithelial to mesenchymal transition in metastatic breast cancer cells

  2017cites this paper
• The clinicopathological significance of RUNX3 hypermethylation and mRNA expression in human breast cancer, a meta-analysis

  2016cites this paper
• BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice

  2016cites this paper
• Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer

  2016cites this paper
• An early biomarker and potential therapeutic target of RUNX 3 hypermethylation in breast cancer, a system review and meta-analysis

  2016cites this paper
• Regulation of transforming growth factor beta (TGFβ) at the level of nuclear entry

  2016cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• Clinicopathological significance and potential drug target of rUnX3 in non-small cell lung cancer: a meta-analysis the mechanism of initiation, progression, and identification of prognostic markers

  2015cites this paper
• Retrospective Study of Adjuvant Chemotherapy Effects on Survival Rate after Three-Field Lymph Node Dissection for Stage IIA Esophageal Cancer.

  2015cites this paper
• Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis

  2015cites this paper
• DNA methylation study of fetus genome through a genome-wide analysis

  2014cites this paper
• Clinicopathological significance and potential drug target of RUNX3 in breast cancer

  2014cites this paper
• Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy

  2014cites this paper
• Proteomic Signatures of the Colorectal Cancer Desmoplastic Invasion Front

  2014cites this paper
• Association between RUNX3 promoter methylation and non-small cell lung cancer: a meta-analysis.

  2014cites this paper
• Relationship between RUNX3 methylation and hepatocellular carcinoma in Asian populations: a systematic review.

  2014cites this paper
• The RUNX family in breast cancer: relationships with estrogen signaling

  2013cites this paper
• Association between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

  2013cites this paper
• RUNX3 gene promoter demethylation by 5-Aza-CdR induces apoptosis in breast cancer MCF-7 cell line

  2013cites this paper
• Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules.

  2013cites this paper
• Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors

  2012cites this paper
• Generation and characterization of Tmeff2 mutant mice.

  2012cites this paper
• RUNX3 methylation as a predictor for disease progression in patients with non‐muscle‐invasive bladder cancer

  2012cites this paper
• Genetic, molecular and microbiological basis for ovarian carcinoma from a low incidence population

  2012cites this paper
• BMP2 Differentially Regulates the Expression of Gremlin1 and Gremlin2, the Negative Regulators of BMP Function, During Osteoblast Differentiation

  2012cites this paper
• TGF-β mediated DNA methylation in prostate cancer

  2012cites this paper
• Global Methylation Analysis Identifies PITX2 as an Upstream Regulator of the Androgen Receptor and IGF-I Receptor Genes in Prostate Cancer

  2012cites this paper
• Tumor suppressor function of RUNX3 in breast cancer

  2012cites this paper
• TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma

  2011cites this paper
• The Tumor Suppressor Activity of the Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 (TMEFF2) Correlates with Its Ability to Modulate Sarcosine Levels*

  2011cites this paper
• Absence of Runx3 expression in normal gastrointestinal epithelium calls into question its tumour suppressor function

  2011cites this paper
• Refined mapping of blood pressure quantitative trait loci using congenic strains developed from two genetically hypertensive rat models

  2011cites this paper
• Epigenetics and diabetic cardiomyopathy.

  2011cites this paper
• Aus der Medizinischen Universitätsklinik mit Poliklinik

  2011cites this paper
• DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.

  2009cites this paper
• Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy

  2009influential citation
• Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer

  2009cites this paper
• DNA Methylation in Colorectal Cancer: Multiple Facets of Tumorigenesis

  2009cites this paper
• The aberrant methylation of TSP1 suppresses TGF‐β1 activation in colorectal cancer

  2008cites this paper
• Nouveaux marqueurs de détection du cancer de la vessie

  2008cites this paper
• Identification and Validation of Colorectal Neoplasia–Specific Methylation Markers for Accurate Classification of Disease

  2007cites this paper
• TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.

  2007cites this paper
• Oncotargets and Therapy Dovepress Dovepress Clinical Significance and Association of Runx3 Hypermethylation Frequency with Colorectal Cancer: a Meta-analysis

  year unknowncites this paper
• Molecular Cancer Identification of a Panel of Sensitive and Specific Dna Methylation Markers for Squamous Cell Lung Cancer

  year unknowncites this paper